Trending...
- Customized Stations Available for Jeron Pro-Alert™ Area of Rescue System
- 99% of lab professionals impacted by medical couriers, survey finds
- How to Fast-Track Your Way to the Top with The Code
New Application Empowers Businesses to Manage Trade Data Quality, Compliance, Sourcing, Inventory Optimization, Supplier/Customer Negotiations, and Bottom-Line Impact
SAN JOSE, Calif. - illiNews -- OpsVeda, the leading provider of AI-driven Operations Command Center, today announced the launch of TariffSight, the world's first, most compelling, and comprehensive application designed to help businesses address the far-reaching implications of trade tariffs. Leveraging OpsVeda's robust and configurable platform, TariffSight enables enterprises to tackle the urgency in compliance, sourcing, inventory, and supplier/customer negotiations, while continuously optimizing operations in response to shifting trade regulations.
From trade item classification checks to real-time margin impact simulations, TariffSight provides the essential capabilities needed by global businesses looking to mitigate risk and ensure bottom-line health. Built upon OpsVeda's unique operational intelligence engine, this groundbreaking solution taps into demand, supply, and inventory data on a continuous basis—ensuring that executives can rapidly adapt their strategies and drive better outcomes across the value chain.
More on illi News
"TariffSight truly is the need of the hour," said Sanjiv Gupta, Founder and CEO at OpsVeda. "Our customers are increasingly grappling with the volatility of global trade regulations, and they need a solution that not only monitors and projects tariff impacts, but also continuously adapts to shifting market conditions. TariffSight is built to be remarkably configurable and extendable—so that every organization can tailor it to their specific needs. Most importantly, it's grounded in real-time demand, supply, and inventory data, which is the vital ingredient for making informed decisions and steering proactive strategies.
Through powerful storyboards, alerts, and advanced analytics, TariffSight addresses:
OpsVeda is an industry leader in operational intelligence, delivering actionable insights to empower businesses in an ever-evolving global market. Its AI-powered platform drives enhanced performance in supply chain, operations, and revenue management, enabling teams to plan and act with agility. OpsVeda solutions incorporate continuous demand, supply, and inventory data, ensuring that enterprises can stay responsive, manage risk, and protect margins across their extended operations.
More on illi News
For more information on TariffSight and other OpsVeda solutions, visit https://www.opsveda.com/TariffSight or contact info@opsveda.com.
From trade item classification checks to real-time margin impact simulations, TariffSight provides the essential capabilities needed by global businesses looking to mitigate risk and ensure bottom-line health. Built upon OpsVeda's unique operational intelligence engine, this groundbreaking solution taps into demand, supply, and inventory data on a continuous basis—ensuring that executives can rapidly adapt their strategies and drive better outcomes across the value chain.
More on illi News
- New Professional Association to Study Principles of Hospitality Applied to the Delivery of Healthcare
- Clinical Endpoints Successfully Met in Study for Groundbreaking 12-Lead ECG Synthesis Technology Allowing Software Application to FDA: HeartBeam, Inc
- DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Medical Express Ambulance, Inc. Customers Whose Data May Have Been Compromised
- Boston Industrial Solutions, Inc. Unveils Natron® 504N UV LED Inks Designed for EPSON Printheads
- Kavelle Christie: Trump's First 100 Days Mark Alarming Breakdown in Healthcare, Public Health, and Freedoms
"TariffSight truly is the need of the hour," said Sanjiv Gupta, Founder and CEO at OpsVeda. "Our customers are increasingly grappling with the volatility of global trade regulations, and they need a solution that not only monitors and projects tariff impacts, but also continuously adapts to shifting market conditions. TariffSight is built to be remarkably configurable and extendable—so that every organization can tailor it to their specific needs. Most importantly, it's grounded in real-time demand, supply, and inventory data, which is the vital ingredient for making informed decisions and steering proactive strategies.
Through powerful storyboards, alerts, and advanced analytics, TariffSight addresses:
- Trade Data Quality: Enabling real-time visibility of inaccurate or incomplete trade data to prevent compliance missteps.
- Compliance & Risk Management: Helping businesses adhere to constantly evolving regulatory requirements through robust analytics and prompt insights.
- Sourcing & Network Optimization: Identifying optimal sourcing strategies and distribution networks to reduce costs and boost flexibility.
- Inventory Optimization: Streamlining stock levels to meet fluctuating demand while minimizing risks associated with sudden tariff changes.
- Trade Negotiations: Providing modeling tools for supplier and customer negotiations, giving companies the leverage they need to safeguard margins.
- Margin Impact Simulations: Delivering what-if analyses that reveal the direct and indirect costs of tariffs on the bottom line, enabling executives to plan, simulate, and act.
OpsVeda is an industry leader in operational intelligence, delivering actionable insights to empower businesses in an ever-evolving global market. Its AI-powered platform drives enhanced performance in supply chain, operations, and revenue management, enabling teams to plan and act with agility. OpsVeda solutions incorporate continuous demand, supply, and inventory data, ensuring that enterprises can stay responsive, manage risk, and protect margins across their extended operations.
More on illi News
- Naperville: 100 Block Locust Court Structure Fire
- Naperville: Bulk Brush Collection to Help Residents With Spring Yard Clean-Ups
- Late-Breaking Research from SK Life Science Labs at AACR Annual Meeting Shows p300-Selective Degraders are Potent Growth Inhibitors in Models of Aggressive Prostate Cancers and Solid Tumors
- OpenSSL Technical Advisory Committee Elections Now Open – Cast Your Vote
- RallyCap Sports Launches New Illinois Chapter: Inclusive Sports Coming to Sheridan!
For more information on TariffSight and other OpsVeda solutions, visit https://www.opsveda.com/TariffSight or contact info@opsveda.com.
Source: OpsVeda, Inc.
0 Comments
Latest on illi News
- People & Stories/Gente y Cuentos Announces New Board Leadership & Corporate Partnership Initiative
- Concert Violinist Addison Teng Redefines Music Education for a New Generation
- How to Fast-Track Your Way to the Top with The Code
- Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025
- Naperville Residents Invited to 'Chat with the Chief' on May 1
- Ultra High Net Worth Team Partners with Arkadios Capital, Establishing Boutique Firm KRM Investment Counsel
- Lyricalmar Set To Release Powerful New Ep "MARCHIVES" May 16
- Water Quality Association's 50th Anniversary Makes a Splash with Interactive Digital Artwork
- Charleston, SC - ACSEC offers Rain Barrels Through Annual Program
- Greek Government Issues Landmark Ministerial Order Addressing Citizenship of Greek-born adoptees
- Baltimore Author Crafts Space Opera Where Human Questions Outshine Galactic Scale
- Stout Surpasses 60,000 Acres and 3 Billion Plants Scanned
- Crescent Grove Advisors Marks a Decade of Independence
- MAJOR New release of Krypto500 (ELF-HF) Sigint - COMINT software
- "The Eyes Have It" a Short Story by Philip K. Dick Now Available on Audiobook
- New Build-to-Suit VA Medical Office Facility Coming to Highland Heights, KY
- Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action
- Locus Robotics Surpasses 5 Billion Pick Milestone, Accelerating Global Adoption of Mobile Warehouse Automation USA - English USA - English
- Kelun-Biotech to Present Results of Six Clinical Studies at 2025 ASCO Annual Meeting